VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: Review of a unique disorder

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1782, Issue 12, 2008, Pages 744-748

  Kimonis, Virginia E ^a   Fulchiero, Erin ^b,c   Vesa, Jouni ^a   Watts, Giles ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

AAA protein; ALS; Alzheimer; FSH; Inclusion body; TDP 43; Ubiquitin; Vacuolar myopathy

Indexed keywords

BETA SECRETASE; PROTEASOME; TAR DNA BINDING PROTEIN; UBIQUITIN; VALOSIN CONTAINING PROTEIN;

ADOLESCENT; ADULT; AGED; BEHAVIOR DISORDER; BINDING SITE; BONE GROWTH; BONE PAIN; CHILD; CYTOPLASM; CYTOSOL; DATA ANALYSIS; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM; FEMALE; FRACTURE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HEART FAILURE; HUMAN; MALE; MISSENSE MUTATION; MUSCLE WEAKNESS; MYOPATHY; PAGET BONE DISEASE; PERSONALITY DISORDER; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; RESPIRATORY FAILURE; REVIEW; SHOULDER; WALKING DIFFICULTY;

ADENOSINE TRIPHOSPHATASES; CELL CYCLE PROTEINS; DEMENTIA; FRONTAL LOBE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUSCULAR DISEASES; MUTATION; OSTEITIS DEFORMANS;

EID: 56449111307     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2008.09.003     Document Type: Review

References (42)

1. Eisenberg I., Avidan N., Potikha T., Hochner H., Chen M., Olender T., Barash M., Shemesh M., Sadeh M., Grabov-Nardini G., Shmilevich I., Friedmann A., Karpati G., Bradley W.G., Baumbach L., Lancet D., Asher E.B., Beckmann J.S., Argov Z., and Mitrani-Rosenbaum S. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat. Genet. 29 (2001) 83-87
2. Kayashima T., Matsuo H., Satoh A., Ohta T., Yoshiura K., Matsumoto N., Nakane Y., Niikawa N., and Kishino T. Nonaka myopathy is caused by mutations in the UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase gene (GNE). J. Hum. Genet. 47 (2002) 77-79
3. Kovach M.J., Waggoner B., Leal S.M., Gelber D., Khardori R., Levenstien M.A., Shanks C.A., Gregg G., Al-Lozi M.T., Miller T., Rakowicz W., Lopate G., Florence J., Glosser G., Simmons Z., Morris J.C., Whyte M.P., Pestronk A., and Kimonis V.E. Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol. Genet. Metab. 74 (2001) 458-475
4. Tucker Jr. W.S., Hubbard W.H., Stryker T.D., Morgan S.W., Evans O.B., Freemon F.R., and Theil G.B. A new familial disorder of combined lower motor neuron degeneration and skeletal disorganization. Trans. Assoc. Am. Physicians 95 (1982) 126-134
5. McBride T.I. Paget's disease and muscular dystrophy. Report of an unusual association in one family. Scott. Med. J. 11 (1966) 238-243
6. Caughey J.E., Gwynne J.F., and Jefferson N.R. Dystrophia myotonica associated with familial Paget's disease (osteitis deformans) with sarcomata. J. Bone Joint Surg. Br. 39-B (1957) 316-325
7. Kimonis V.E., Kovach M.J., Waggoner B., Leal S., Salam A., Rimer L., Davis K., Khardori R., and Gelber D. Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone. Genet. Med. 2 (2000) 232-241
8. Foster N.L., Wilhelmsen K., Sima A.A., Jones M.Z., D'Amato C.J., and Gilman S. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants. Ann. Neurol. 41 (1997) 706-715
9. Rosso S.M., Kamphorst W., de Graaf B., Willemsen R., Ravid R., Niermeijer M.F., Spillantini M.G., Heutink P., and van Swieten J.C. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. Brain 124 (2001) 1948-1957
10. Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J., Rademakers R., Lindholm C., Snowden J., Adamson J., Sadovnick A.D., Rollinson S., Cannon A., Dwosh E., Neary D., Melquist S., Richardson A., Dickson D., Berger Z., Eriksen J., Robinson T., Zehr C., Dickey C.A., Crook R., McGowan E., Mann D., Boeve B., Feldman H., and Hutton M. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442 (2006) 916-919
11. Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., Pirici D., Rademakers R., Vandenberghe R., Dermaut B., Martin J.J., van Duijn C., Peeters K., Sciot R., Santens P., De Pooter T., Mattheijssens M., Van den Broeck M., Cuijt I., Vennekens K., De Deyn P.P., Kumar-Singh S., and Van Broeckhoven C. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442 (2006) 920-924
12. Watts G.D., Wymer J., Kovach M.J., Mehta S.G., Mumm S., Darvish D., Pestronk A., Whyte M.P., and Kimonis V.E. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36 (2004) 377-381
13. Schroder R., Watts G.D., Mehta S.G., Evert B.O., Broich P., Fliessbach K., Pauls K., Hans V.H., Kimonis V., and Thal D.R. Mutant valosin-containing protein causes a novel type of frontotemporal dementia. Ann. Neurol. 57 (2005) 457-461
14. Guyant-Marechal L., Laquerriere A., Duyckaerts C., Dumanchin C., Bou J., Dugny F., Le Ber I., Frebourg T., Hannequin D., and Campion D. Valosin-containing protein gene mutations: clinical and neuropathologic features. Neurology 67 (2006) 644-651
15. Haubenberger D., Bittner R.E., Rauch-Shorny S., Zimprich F., Mannhalter C., Wagner L., Mineva I., Vass K., Auff E., and Zimprich A. Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene. Neurology 65 (2005) 1304-1305
16. Watts G.D., Thomasova D., Ramdeen S.K., Fulchiero E.C., Mehta S.G., Drachman D.A., Weihl C.C., Jamrozik Z., Kwiecinski H., Kaminska A., and Kimonis V.E. Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. Clin. Genet. 72 (2007) 420-426
17. Alvarez A., Simmons Z., and Askanas E.W.K.V. New autosomal dominant inclusion body myopathy (AD-IBM) with many congophilic muslce nuclei that contain paired-helical filaments (PHFs) composed of phosphorylated tau. Neuro 50 (1998) A204
18. T.P. Weihl, C.C. Miller, S.E. Watts, G. Smith, C. Forman, M. Hanson, P.I. Kimonis, and A. Pestronk, TDP-43 accumulation in IBM muscle suggests a common pathogenic mechanism with Frontotemporal dementia, (2008).
19. Neumann M., Mackenzie I.R., Cairns N.J., Boyer P.J., Markesbery W.R., Smith C.D., Taylor J.P., Kretzschmar H.A., Kimonis V.E., and Forman M.S. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J. Neuropathol. Exp. Neurol. 66 (2007) 152-157
20. Ralston S.H., Langston A.L., and Reid I.R. Pathogenesis and management of Paget's disease of bone. Lancet 372 (2008) 155-163
21. Mehta S.G., Watts G.D., Adamson J.L., Hutton M., Umberger G., Xiong S., Ramdeen S., Lovell M.A., Kimonis V.E., and Smith C.D. APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD). Genet. Med. 9 (2007) 9-13
22. Forman M.S., Mackenzie I.R., Cairns N.J., Swanson E., Boyer P.J., Drachman D.A., Jhaveri B.S., Karlawish J.H., Pestronk A., Smith T.W., Tu P.H., Watts G.D., Markesbery W.R., Smith C.D., and Kimonis V.E. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J. Neuropathol. Exp. Neurol. 65 (2006) 571-581
23. Kimonis V.E., Mehta S.G., Fulchiero E.C., Thomasova D., Pasquali M., Boycott K., Neilan E.G., Kartashov A., Forman M.S., Tucker S., Kimonis K., Mumm S., Whyte M.P., Smith C.D., and Watts G.D. Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am. J. Med. Genet. A. 146 (2008) 745-757
24. Zhang X., Shaw A., Bates P.A., Newman R.H., Gowen B., Orlova E., Gorman M.A., Kondo H., Dokurno P., Lally J., Leonard G., Meyer H., van Heel M., and Freemont P.S. Structure of the AAA ATPase p97. Mol. Cell. 6 (2000) 1473-1484
25. DeLaBarre B., and Brunger A.T. Complete structure of p97/valosin-containing protein reveals communication between nucleotide domains. Nat. Struct. Biol. 10 (2003) 856-863
26. Richly H., Rape M., Braun S., Rumpf S., Hoege C., and Jentsch S. A series of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting. Cell 120 (2005) 73-84
27. Rabinovich E., Kerem A., Frohlich K.U., Diamant N., and Bar-Nun S. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol. Cell. Biol. 22 (2002) 626-634
28. Ye Y., Meyer H.H., and Rapoport T.A. The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 414 (2001) 652-656
29. Hirabayashi M., Inoue K., Tanaka K., Nakadate K., Ohsawa Y., Kamei Y., Popiel A.H., Sinohara A., Iwamatsu A., Kimura Y., Uchiyama Y., Hori S., and Kakizuka A. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell. Death Differ. 8 (2001) 977-984
30. Kobayashi T., Tanaka K., Inoue K., and Kakizuka A. Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells. J. Biol. Chem. 277 (2002) 47358-47365
31. Weihl C.C., Miller S.E., Hanson P.I., and Pestronk A. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice. Hum. Mol. Genet. 16 (2007) 919-928
32. Weihl C.C., Dalal S., Pestronk A., and Hanson P.I. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. Hum. Mol. Genet. 15 (2006) 189-199
33. Kakizuka A. Roles of VCP in human neurodegenerative disorders. Biochem. Soc. Trans. 36 (2008) 105-108
34. Hocking L.J., Lucas G.J., Daroszewska A., Mangion J., Olavesen M., Cundy T., Nicholson G.C., Ward L., Bennett S.T., Wuyts W., Van Hul W., and Ralston S.H. Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum. Mol. Genet. 11 (2002) 2735-2739
35. Kuusisto E., Salminen A., and Alafuzoff I. Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. Neuroreport 12 (2001) 2085-2090
36. Anderson D.M., Maraskovsky E., Billingsley W.L., Dougall W.C., Tometsko M.E., Roux E.R., Teepe M.C., DuBose R.F., Cosman D., and Galibert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390 (1997) 175-179
37. Daroszewska A., and Ralston S.H. Genetics of Paget's disease of bone. Clin. Sci. (Lond). 109 (2005) 257-263
38. Bersano A., Del Bo R., Lamperti C., Ghezzi S., Fagiolari G., Fortunato F., Ballabio E., Moggio M., Candelise L., Galimberti D., Virgilio R., Lanfranconi S., Torrente Y., Carpo M., Bresolin N., Comi G.P., and Corti S. Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation. Neurobiol. Aging. (2007) Available online 24 September 2007
39. Viassolo V., Previtali S.C., Schiatti E., Magnani G., Minetti C., Zara F., Grasso M., Dagna-Bricarelli F., and Di Maria E. Inclusion body myopathy, Paget's disease of the bone and frontotemporal dementia: recurrence of the VCP R155H mutation in an Italian family and implications for genetic counselling. Clin. Genet. 74 (2008) 54-60
40. Gidaro T., Modoni A., Sabatelli M., Tasca G., Broccolini A., and Mirabella M. An Italian family with inclusion-body myopathy and frontotemporal dementia due to mutation in the VCP gene. Muscle Nerve 37 (2008) 111-114
41. Viassolo V., Previtali S.C., Schiatti E., Magnani G., Minetti C., Zara F., Grasso M., Dagna-Bricarelli F., and Di Maria E. Inclusion body myopathy, Paget's disease of the bone and frontotemporal dementia: recurrence of the VCP R155H mutation in an Italian family and implications for genetic counselling. Clin. Genet. 74 (2008) 54-60
42. Spina S., Van Laar A.D., Murrell J.R., de Courten-Myers G., Hamilton R.L., Farlow M.R., Quinlan J., DeKosky S.T., and Ghetti B. Frontotemporal dementia associated with a Valosin-Containing Protein mutation: report of three families. FASEB J. 22 (2008) 58.4